INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)

2021

1. A host transcriptomic signature for identification of respiratory viral infections in the community

   European Journal of Clinical Investigation, Vol. 51, Núm. 12

2. ARID1A genomic alterations driving microsatellite instability through somatic MLH1 methylation with response to immunotherapy in metastatic lung adenocarcinoma: a case report

   Journal of Medical Case Reports, Vol. 15, Núm. 1

3. Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation

   International Journal of Pharmaceutics, Vol. 599

4. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

   Journal of Clinical Investigation, Vol. 131, Núm. 23

5. An Evolutionary Perspective of the Lipocalin Protein Family

   Frontiers in Physiology, Vol. 12

6. Analyzing the impact of COVID-19 trauma on developing post-traumatic stress disorder among emergency medical workers in Spain

   International Journal of Environmental Research and Public Health, Vol. 18, Núm. 17

7. Anthracyclins increase pufas: Potential implications in er stress and cell death

   Cells, Vol. 10, Núm. 5

8. Antiviral activities of halogenated emodin derivatives against human coronavirus nl63

   Molecules, Vol. 26, Núm. 22

9. Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case–control study

   Scientific Reports, Vol. 11, Núm. 1

10. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke

    European Journal of Neurology, Vol. 28, Núm. 2, pp. 540-547

11. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

12. Cell therapy for colorectal cancer: The promise of chimeric antigen receptor (car)‐t cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

13. Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry

    International Journal of Stroke, Vol. 16, Núm. 4, pp. 437-447

14. Chronic intermittent hypoxia induces early-stage metabolic dysfunction independently of adipose tissue deregulation

    Antioxidants, Vol. 10, Núm. 8

15. Circulating AQP4 levels in patients with cerebral amyloid angiopathy-associated intracerebral hemorrhage

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-15

16. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients

    Translational Research, Vol. 236, pp. 147-159

17. Clinically used JAK inhibitor blunts dsRNA-induced inflammation and calcification in aortic valve interstitial cells

    FEBS Journal, Vol. 288, Núm. 22, pp. 6528-6542

18. Comparison of plasma lipoprotein composition and function in cerebral amyloid angiopathy and alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 1, pp. 1-14

19. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

20. Comprehensive post-stroke rehabilitation: Its long-term effects and the socio-environmental factors conditioning access to it

    Revista de Neurologia, Vol. 73, Núm. 1, pp. 1-9